In late February, President Biden issued two executive orders (14001 and 14017) focused on creating “resilient, diverse, and secure supply chains” to ensure economic prosperity and national security. These executive orders were issued in response to the COVID-19 pandemic, which caused major disruptions in manufacturing and supply chains, especially for critical medical products such as personal protective equipment (PPE).
How can healthcare providers apply pandemic supply chain lessons to build more resilient organizations and protect the health of their patients?
Learn more now.
OPTIONS TO SUPPORT VIABILITY FOR AUSTRALIA’S PRIVATE HOSPITAL SYSTEM
July 3, 2025
The Australian healthcare system has long been recognised as a global leader, balancing public, and private care to deliver exceptional outcomes for patients.This paper outlines a pathway to safeguard the future of Australia’s private hospital network
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.